Blackstone’s bid to acquire I’rom raises competition concerns over clinical trials

Healthcare 2024-11-07 11:32 pm By Julia Kanapathippillai | Canberra

The ACCC has red flags about the acquisition of Japanese healthcare business I’rom Group by private equity behemoth Blackstone.